2.15000 USD
0.01
0.46%
Last update Dec 17, 3:51 PM EST
Pre-market
Day range
2.10200
2.26000
Previous close
2.16000
Open
2.23000
Access this stock data via API
Subscribe
Alzamend Neuro Inc.
2.15
0.01
0.46%

Financials

Income statement

Fiscal date Oct 2025 Jul 2025 Apr 2025 Jan 2025
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 176.3K 1.7M 450.2K 447.1K
Selling general and admin 821.8K 959.3K 688.8K 590.3K
Other operating expenses
Operating income -998.1K -2.7M -1.1M -1.0M
Non operating interest income
Income
Expense 2.6K 2.5K 509 2.0K
Other income expense
Pretax income -1.0M -2.7M -1.1M -1.0M
Tax provision
Net income -1.0M -2.7M -1.1M -1.0M
Basic EPS -0.3 -1.3 -1.7
Diluted EPS -0.3 -1.3 -1.7
Basic average shares 3.4M 2.1M 613.1K
Diluted average shares 3.4M 2.1M 613.1K
EBITDA -970.4K -2.7M -1.1M -1.0M
Net income from continuing op. -1.0M -2.7M -1.1M -985.8K
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Pre-market

Exchange is currently open for pre-market.
Main market opens in 1 hour 38 minutes

07:51
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).